ScholarIQanswers from OpenAlex

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors

PaperCitations, authors & open-access status

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors have?

ScholarIQcitation count

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors has 14 citations in the OpenAlex counts ScholarIQ stores.

When was Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors published?

ScholarIQyear

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors has 2012 year in the ScholarIQ index.

What is the open-access status of Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors?

ScholarIQoa status

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors has closed oa status in the ScholarIQ index.

What is the DOI of Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors?

ScholarIQdoi

The DOI for Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors is on the source record.

What is the PMID of Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors?

ScholarIQpmid

The PMID for Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors is on the source record.

What is the OpenAlex record for Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors?

ScholarIQopenalex

The OpenAlex for Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial